Filters
cris logo
-
New search Filters
Select from list
Displayed from Show more
You have reached the maximum number of displayed search results.
All results displayed
No results are available for the search performed
Displayed from
You have reached the maximum number of displayed search results.
All results displayed
Loading results
Obtaining statistical data

PhD Maša Omerzel

PhD Maša Omerzel
no.: 34373 source: ARIS

researcher – active in research organisation
Edit
Research activity

Code Science Field Subfield
3.00.00  Medical sciences     
3.04.00  Medical sciences  Oncology   
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Evaluation (rules)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
560.45
A''
43.81
A'
345.19
A1/2
431.73
CI10
468
CImax
41
h10
12
A1
2.04
A3
4.61
Data for the last 5 years (citations for the last 10 years) on April 25, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 12.01.2024 – Project tender, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 62  685  357  5.76 
Scopus 63  838  473  7.51 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 PhD Tilen Komel  Bologna doctoral studies  10/1/2019 - 9/30/2023  53504 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (100%, RD:100%)  Institute of Oncology Ljubljana  Department of research 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J3-50108  DEBIO 1143 has a potential to increase effectiveness of electrochemotherapy and radiotherapy in HPV positive and HPV negative Head and Neck Cancers   2023 - 2024  PhD Katarina Žnidar  2,193 
2. J4-50150  Erythrocyte membrane-based nanocarriers for gene silencing cancer therapy   2023 - 2024  PhD Nina Kostevšek  3,905 
3. L3-50111  Gene immuno-therapy of solid tumors based on mRNA encoding interleukin-12: So-rIL   2023 - 2024  PhD Maja Čemažar  2,833 
4. J3-50110  Intratumoral mRNA electrotransfer: establishment and preclinical proof of concept   2023 - 2024  PhD Katja Uršič Valentinuzzi  3,084 
5. J1-4417  Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy   2022 - 2024  PhD Matej Sova  3,919 
6. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   2022 - 2024  PhD Lucija Peterlin Mašič  6,051 
7. L7-4491  Development of integrated multi-channel artificial nose for detection of cancer   2022 - 2023  PhD Igor Muševič  5,471 
8. J3-4504  Uncovering the glioblastoma microenvironment to enhance the therapy   2022 - 2023  PhD Metka Novak  1,775 
9. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   2022 - 2023  PhD Gregor Serša  6,770 
10. Z3-1871  Combination of electrochemotherapy with poly (adenosin diphosphate-ribose) polymerase inhibitor in treatment of breast cancer   2019 - 2021  PhD Maša Omerzel  198 
11. L2-7550  Elecrospun nanofibrous materials for solid state drug delivery system   2016  PhD Igor Emri  4,425 
12. J3-7494  Tunneling nanotubes for innovative urinary bladder cancer treatments   2016  PhD Mateja Erdani Kreft  7,081 
13. J1-6730  Development of new hepatic cell lines for genotoxicity and carcinogenicity studies: new hope for human health and laboratory animal welfare protection   2015 - 2016  PhD Metka Filipič  4,045 
14. J3-6796  Translational oncology: development and validtion of immunogene therapy with Interleukin-12 combined with surgery for canine cancers of the oral cavity and skin   2015 - 2016  PhD Maja Čemažar  4,739 
15. J3-6793  New approaches of tumor radiosenzibilization with gene therapy   2014 - 2016  PhD Gregor Serša  5,092 
16. J3-5505  Electrochemotherapy in treatment of deep seated tumors   2013 - 2016  PhD Gregor Serša  4,269 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P3-0003  Development and evaluation of new approaches to cancer treatment   2022 - 2024  PhD Gregor Serša  3,948 
2. P3-0003  Development and evaluation of new approaches to cancer treatment   2015 - 2021  PhD Gregor Serša  3,264 
3. P3-0003  Development and evaluation of new approaches to cancer treatment   2011 - 2014  PhD Gregor Serša  4,018 
We were not given permission by the researcher to publish data.
Confirmation required
Views history
Favourite